Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Oct;46(10):e13067.
doi: 10.1111/pim.13067.

The Effect of Malaria on Responses to Unrelated Vaccines in Animals and Humans: A Systematic Review and Meta-Analysis

Ludoviko Zirimenya  1   2 , Agnes Natukunda  1   3 , Jacent Nassuuna  1 , Joyce Kabagenyi  4 , Gyaviira Nkurunungi  1   5 , Alison M Elliott  1   2 , Emily L Webb  3
Affiliations
Meta-Analysis

The Effect of Malaria on Responses to Unrelated Vaccines in Animals and Humans: A Systematic Review and Meta-Analysis

Ludoviko Zirimenya et al. Parasite Immunol. 2024 Oct.

Abstract

Vaccine efficacy varies globally, often showing reduced immune responses in low- and middle-income countries, possibly due to the immunomodulatory effects of parasitic infections like malaria. This systematic review evaluates the impact of malaria on immune responses to unrelated vaccines in humans and animals. We systematically searched five databases-MEDLINE, Web of Science, Global Health, Scopus and Embase-up to 5th December 2023. Eligible studies compared immune responses to WHO-approved vaccines between malaria-infected and uninfected groups, or between antimalarial-treated and untreated groups. Meta-analysis was performed using random-effects models with standardised mean differences (SMDs) as summary statistics. The study is registered with PROSPERO (CRD42022298053). Twenty-four articles (17 human, 7 animal) met the inclusion criteria, with 13 human articles contributing data for the meta-analysis. Significant heterogeneity was observed. Vaccine responses were higher in malaria uninfected individuals (SMD 0.34, 95% CI 0.07 to 0.60, I2 = 87.15%) with weaker differences between antimalarial-treated and untreated groups (SMD 0.07, 95% CI -0.01 to 0.16, I2 = 85.01%). The overall SMD for malaria uninfected/treated vs. infected/untreated was 0.15, 95% CI 0.05-0.26, I2 = 90.91. Narrative analysis suggested malaria's adverse impact on vaccine responses in animals. Malaria infection may impair vaccines responses; with preventive treatment of malaria partially reversing these effects, highlighting the need for targeted public health interventions.

Keywords: immunity; malaria; meta‐analysis; systematic review; vaccines.

PubMed Disclaimer

References

    1. WHO, Immunization Agenda 2030: A Global Strategy to Leave No One Behind (Geneva: WHO, 2020).
    1. M. van Dorst, J. J. Pyuza, G. Nkurunungi, et al., “Immunological Factors Linked to Geographical Variation in Vaccine Responses,” Nature Reviews Immunology 24 (2023): 250–263.
    1. P. E. Fine, “Variation in Protection by BCG: Implications of and for Heterologous Immunity,” Lancet 346, no. 8986 (1995): 1339–1345.
    1. M. Taniuchi, J. A. Platts‐Mills, S. Begum, et al., “Impact of Enterovirus and Other Enteric Pathogens on Oral Polio and Rotavirus Vaccine Performance in Bangladeshi Infants,” Vaccine 34, no. 27 (2016): 3068–3075.
    1. A. J. Cunnington and E. M. Riley, “Suppression of Vaccine Responses by Malaria: Insignificant or Overlooked?” Expert Review of Vaccines 9, no. 4 (2010): 409–429.

LinkOut - more resources